| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Damps T et al. | The effect of wool hydrolysates on squamous cell carcinoma cells in vitro. Possible implications for cancer treatment. | 2017 | PLoS ONE | pmid:28859143 |
| Asche CV et al. | Evaluation of Resource Utilization and Treatment Patterns in Patients with Actinic Keratosis in the United States. | 2016 Mar-Apr | Value Health | pmid:27021759 |
| Zane C et al. | A Randomized Split-Face Clinical Trial of Photodynamic Therapy with Methyl Aminolevulinate versus Ingenol Mebutate Gel for the Treatment of Multiple Actinic Keratoses of the Face and Scalp. | 2016 | Dermatology (Basel) | pmid:27578305 |
| Mühlstädt M | Ingenol Mebutate vs. Daylight Photodynamic Therapy in a Kidney Transplant Recipient. | 2016 | Dermatology (Basel) | pmid:27513345 |
| Erlendsson AM et al. | Repeated Treatments with Ingenol Mebutate Prevents Progression of UV-Induced Photodamage in Hairless Mice. | 2016 | PLoS ONE | pmid:27636884 |
| Emmert S et al. | Tumor-Preferential Induction of Immune Responses and Epidermal Cell Death in Actinic Keratoses by Ingenol Mebutate. | 2016 | PLoS ONE | pmid:27612149 |
| Liu M et al. | Synthesis and Cytotoxicity against K562 Cells of 3-O-Angeloyl-20-O-acetyl Ingenol, a Derivative of Ingenol Mebutate. | 2016 | Int J Mol Sci | pmid:27548156 |
| Mohanna MT and Hofbauer GF | Bowenoid Actinic Keratosis and Bowen's Disease Treated Successfully with Ingenol Mebutate. | 2016 | Dermatology (Basel) | pmid:27513957 |
| Mainetti C et al. | Successful Treatment of Relapsing Bowen's Disease with Ingenol Mebutate: The Use of Dermoscopy to Monitor the Therapeutic Response. | 2016 | Dermatology (Basel) | pmid:27513936 |
| Gaide O et al. | Ingenol Mebutate 500 μg for Treatment of the Scalp in Refractory Field Cancerization. | 2016 | Dermatology (Basel) | pmid:27513862 |
| Gaide O and Cattin V | Ingenol Mebutate 500 µg on the Cheekbones with Concomitant Conjunctivitis. | 2016 | Dermatology (Basel) | pmid:27513756 |
| Tzika E et al. | Ingenol Mebutate for Recalcitrant Chronic Actinic Cheilitis. | 2016 | Dermatology (Basel) | pmid:27513668 |
| Stieger M and Hunger RE | Ingenol Mebutate Treatment in a Patient with Gorlin Syndrome. | 2016 | Dermatology (Basel) | pmid:27513585 |
| Gadaldi K et al. | Ingenol Mebutate for Lentigo Maligna: A Case Report. | 2016 | Dermatology (Basel) | pmid:27513527 |
| Alkhalaf A and Hofbauer GF | Ingenol Mebutate 150 mg as Physician-Directed Treatment of Bowen's Disease Under Occlusion. | 2016 | Dermatology (Basel) | pmid:27512986 |
| Le TT et al. | IL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate. | 2016 | PLoS ONE | pmid:27100888 |
| Stockfleth E et al. | New Topical Treatment Options for Actinic Keratosis: A Systematic Review. | 2016 | Acta Derm. Venereol. | pmid:26068001 |
| Bhandari PR and Pai VV | Could ingenol mebutate be useful in managing nonmelanoma skin cancers? | 2015 Apr-Jun | Indian J Cancer | pmid:26853424 |
| De Felice B et al. | Ingenol mebutate treatment in keloids. | 2015 | BMC Res Notes | pmid:26391582 |
| Pellacani G et al. | A randomized trial comparing simultaneous vs. sequential field treatment of actinic keratosis with ingenol mebutate on two separate areas of the head and body. | 2015 | J Eur Acad Dermatol Venereol | pmid:26300464 |
Ingenol 3-angelate
Ingenol 3-angelate is a lipid of Fatty Acyls (FA) class.
Cross Reference
